标题
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-11
DOI
10.3389/fcell.2021.570898
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions
- (2019) James R. Birtley et al. Nature Communications
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges
- (2018) Martin Widschwendter et al. Nature Reviews Clinical Oncology
- The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer
- (2017) Elisa Zanini et al. MOLECULAR CANCER THERAPEUTICS
- A DNA methylation map of human cancer at single base-pair resolution
- (2017) E Vidal et al. ONCOGENE
- Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
- (2017) Bi Wang et al. Oncology Letters
- The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
- (2017) Lele Song et al. Scientific Reports
- The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
- (2017) Martin Widschwendter et al. Genome Medicine
- Application of Multiplex Nested Methylated Specific PCR in Early Diagnosis of Epithelial Ovarian Cancer
- (2015) Bi Wang et al. Asian Pacific Journal of Cancer Prevention
- Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation
- (2015) Garth H. Rauscher et al. BMC CANCER
- Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer
- (2015) B.L. Xing et al. GENETICS AND MOLECULAR RESEARCH
- Detection of Circulating Methylated Opioid Binding Protein/Cell Adhesion Molecule-Like Gene as a Biomarker for Ovarian Carcinoma
- (2014) Feng Zhou et al. Clinical Laboratory
- Associated Analysis of DNA Methylation for Cancer Detection Using CCP-Based FRET Technique
- (2013) Jiangyan Zhang et al. ANALYTICAL CHEMISTRY
- Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival
- (2013) Feng Zhou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- New Roles Opined for OPCML: Figure 1.
- (2012) Sherry Y. Wu et al. Cancer Discovery
- The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer
- (2012) Arthur B. McKie et al. Cancer Discovery
- DNA methylation signatures for breast cancer classification and prognosis
- (2012) Moshe Szyf Genome Medicine
- CpG-island methylation study of liver fluke-related cholangiocarcinoma
- (2011) R Sriraksa et al. BRITISH JOURNAL OF CANCER
- Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma
- (2011) Sara Duarte-Pereira et al. EUROPEAN JOURNAL OF CANCER
- OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
- (2008) Yan Cui et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now